Dr. Kelly is the CEO of the International Association for the Study of Lung Cancer (IASLC), the only global network dedicated to the study and eradication of lung cancer and other thoracic malignancies. She is an internationally recognized lung cancer expert dedicated to providing enhanced cancer care through cutting-edge clinical trials. Her research spans the spectrum of this disease from prevention to treatment. Dr. Kelly is widely published, and she frequently lectures on lung cancer topics, nationally and internationally. Dr. Kelly is a long-standing active member of IASLC, ASCO, and SWOG. She served as the SWOG Lung Committee Chair from 2016 until 2022.
Dr. Kelly earned her medical degree from the University of Kansas School of Medicine. She completed her internal medicine residency and oncology fellowship at the University of Colorado Health Sciences Center in Denver, Colorado. Dr. Kelly was appointed faculty at the University of Colorado where she spent many years building her academic career in thoracic oncology prior to accepting a faculty appointment at the University of California, Davis where she held the Jennifer Rene Harmon Tegley and Elizabeth Erica Harmon Endowed Chair in Clinical Cancer Research and was the Associate Director for Clinical Research for their NCI designated comprehensive cancer center